Aggressiveness of cancer care near the end of life: Is it a quality-of-care issue?

Journal of Clinical Oncology

Volumn 26, Issue 23, 2008, Pages 3860-3866

  Earle, Craig C ^a   Landrum, Mary Beth ^a   Souza, Jeffrey M ^a   Neville, Bridget A ^a   Weeks, Jane C ^a   Ayanian, John Z ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

AGGRESSIVENESS; CANCER PATIENT; CHEMOTHERAPY; EMERGENCY WARD; HEALTH CARE QUALITY; HOSPICE; HUMAN; INTENSIVE CARE UNIT; MEDICAL PRACTICE; NEOPLASM; PATIENT CARE; PATIENT REFERRAL; PRIORITY JOURNAL; REVIEW; TERMINAL CARE;

AGED; ANTINEOPLASTIC AGENTS; HOSPICE CARE; HUMANS; LOGISTIC MODELS; NEOPLASMS; PATIENT SATISFACTION; PHYSICIAN'S PRACTICE PATTERNS; QUALITY ASSURANCE, HEALTH CARE; SEER PROGRAM; TERMINAL CARE;

EID: 51349138014     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.15.8253     Document Type: Review

References (39)

1. Rowland J, Mariotto A, Aziz N, et al: Cancer survivorship: United States, 1971-2001. MMWR 53:526-529, 2004
2. National Cancer Policy Board: Ensuring Quality Cancer Care. Washington, DC, National Academy Press, 1999
3. Earle CC, Park ER, Lai B, et al: Identifying potential indicators of the quality of end-of-life cancer care from administrative data. J Clin Oncol 21:1133-1138, 2003
4. Earle CC, Neville BA, Landrum MB, et al: Evaluating claims-based indicators of the intensity of end-of-life cancer care. Int J Qual Health Care 17:505-509, 2005
5. Earle CC, Neville BA, Landrum ME, et al: Trends in the aggressiveness of cancer care near the end of life. J Clin Oncol 22:315-321, 2004
6. Lamont EB, Christakis NA: Physician factors in the timing of cancer patient referral to hospice palliative care. Cancer 94:2733-2737, 2002
7. Grunfeld E, Lethbridge L, Dewar R, et al: Towards using administrative databases to measure population-based indicators of quality of end-of-life care: Testing the methodology. Palliat Med 20:769-777, 2006
8. Murillo JR Jr, Koeller J: Chemotherapy given near the end of life by community oncologists for advanced non-small cell lung cancer. Oncologist 11:1095-1099, 2006
9. Emanuel EJ, Young-Xu Y, Levinsky NG, et al: Chemotherapy use among Medicare beneficiaries at the end of life. Ann Intern Med 138:639-643, 2003
10. Voogt E, van der HA, Rietjens JA, et al: Attitudes of patients with incurable cancer toward medical treatment in the last phase of life. J Clin Oncol 23:2012-2019, 2005
11. Barnato AE, Herndon MB, Anthony DL, et al: Are regional variations in end-of-life care intensity explained by patient preferences? A study of the US Medicare population. Med Care 45:386-393, 2007
12. von Gunten CF: Discussing hospice care. J Clin Oncol 21:31s-36s, 2003
13. Jacobson M, O'Malley AJ, Earle CC, et al: Does reimbursement influence chemotherapy treatment for cancer patients? Health Aff (Millwood) 25:437-443, 2006
14. Mack JW, Cook EF, Wolfe J, et al: Understanding of prognosis among parents of children with cancer: Parental optimism and the parent-physician interaction. J Clin Oncol 25:1357-1362, 2007
15. Lee SJ, Fairclough D, Antin JH, et al: Discrepancies between patient and physician estimates for the success of stem cell transplantation. JAMA 285:1034-1038, 2001
16. Weissman DE, O'Donnell J, Brady A: A cry from the fringe. J Clin Oncol 11:1006, 1993
17. Weeks JC, Cook EF, O'Day SJ, et al: Relationship between cancer patients' predictions of prognosis and their treatment preferences. JAMA 279:1709-1714, 1998
18. Matsuyama R, Reddy S, Smith TJ: Why do patients choose chemotherapy near the end of life? A review of the perspective of those facing death from cancer. J Clin Oncol 24:3490-3496, 2006
19. Slevin ML, Stubbs L, Plant HJ, et al: Attitudes to chemotherapy: Comparing views of patients with cancer with those of doctors, nurses, and general public. BMJ 300:1458-1460, 1990
20. Mack JW, Wolfe J, Cook EF, et al: Hope and prognostic disclosure. J Clin Oncol 25:5636-5642, 2007
21. Virnig BA, Kind S, McBean M, et al: Geographic variation in hospice use prior to death. J Am Geriatr Soc 48:1117-1125, 2000
22. McCarthy EP, Burns RB, Ngo-Metzger Q, et al: Hospice use among Medicare managed care and fee-for-service patients dying with cancer. JAMA 289:2238-2245, 2003
23. Keating NL, Herrinton LJ, Zaslavsky AM, et al: Variations in hospice use among cancer patients. J Natl Cancer Inst 98:1053-1059, 2006
24. Virnig BA, Ma H, Hartman LK, et al: Access to home-based hospice care for rural populations: Identification of areas lacking service. J Palliat Med 9:1292-1299, 2006
25. Virnig BA, Fisher ES, McBean MA, et al: Hospice use in Medicare managed care and fee-for-service systems. Am J Manag Care 7:777-786, 2001
26. Daugherty CK: Examining ethical dilemmas as obstacles to hospice and palliative care for advanced cancer patients. Cancer Invest 22:123-131, 2004
27. Christakis NA, Escarce JJ: Survival of Medicare patients after enrollment in hospice programs. N Engl J Med 335:172-178, 1996
28. Neuss MN, Jacobson JO, Earle C, et al: Evaluating end of life care: The Quality Oncology Practice Initiative (QOPI) experience. J Clin Oncol 20:486s, 2006 (suppl; abstr 8573)
29. Wennberg JE, Fisher ES, Stukel TA, et al: Use of hospitals, physician visits, and hospice care during last six months of life among cohorts loyal to highly respected hospitals in the United States. BMJ 328:607, 2004
30. Makuc DM, Haglund B, Ingram DD, et al: Vital and Health Statistics: Health Service Areas for the United States - Series 2: Data Evaluation and Methods Research 112. DHHS Publication No. (PHS) 92-1386, 1991
31. Grunfeld E, Coyle D, Whelan T, et al: Family caregiver burden: Results of a longitudinal study of breast cancer patients. CMAJ 170:1795-1801, 2004
32. Kristjanson L: Validity and reliability testing of the FAMCARE scale: Measuring family satisfaction with advanced cancer care. Soc Sci Med 36:693-701, 1993
33. Ayanian JZ, Chrischilles EA, Fletcher RH, et al: Understanding cancer treatment and outcomes: The Cancer Care Outcomes Research and Surveillance Consortium. J Clin Oncol 22:2992-2996, 2004
34. Donabedian A: The quality of care: How can it be assessed? JAMA 260:1743-1748, 1988
35. Bach PB, Schrag D, Begg CB: Resurrecting treatment histories of dead patients: A study design that should be laid to rest. JAMA 292:2765-2770, 2004
36. Earle CC, Ayanian JZ: Looking back from death: The value of retrospective studies of end-of-life care. J Clin Oncol 24:838-840, 2006
37. Glare P, Virik K, Jones M, et al: A systematic review of physicians' survival predictions in terminally ill cancer patients. BMJ 327:195-198, 2003
38. Stone PC, Lund S: Predicting prognosis in patients with advanced cancer. Ann Oncol 18:971-976, 2007
39. Benner SE, Fetting JH, Brenner MH: A stopping rule for standard chemotherapy for metastatic breast cancer: Lessons from a survey of Maryland medical oncologists. Cancer Invest 12:451-455, 1994